SCHEMBL32690708

SCHEMBL32690708

Brc1coc2c1oc1ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
MAOA P21397 4/20 0.39
MAPT P10636 3/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 2/20 0.39
HPGD P15428 2/20 0.39
CASP7 P55210 2/20 0.39
HSD17B10 Q99714 2/20 0.39
GLA P06280 1/20 0.39
PGAM1 P18669 1/20 0.39
CASP1 P29466 1/20 0.39
AHR P35869 1/20 0.38
CDC14B O60729 1/20 0.38
CDC14A Q9UNH5 1/20 0.38
LIMK1 P53667 1/20 0.36
KDM5A P29375 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALPI P09923 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9065424 0.75 KDM4E (0.55) KDM4EMAOAMAPTALDH1A1SMN1; SMN2
SCHEMBL24445955 0.72 ALDH1A1 (0.39) KDM4EMAOAMAPTALDH1A1SMN1; SMN2
SCHEMBL6008 0.72 MAOB (0.44) KDM4EMAOAMAPTALDH1A1
SCHEMBL29874833 0.72 MAOB (0.44) KDM4EMAOAMAPTALDH1A1
SCHEMBL636238 0.71 ALOX5 (0.46) KDM4EMAOAMAPTALDH1A1SMN1; SMN2
SCHEMBL29552175 0.71 ALOX5 (0.46) KDM4EMAOAMAPTALDH1A1SMN1; SMN2
SCHEMBL17253012 0.69 CDC14B (0.56) KDM4EMAOAMAPTALDH1A1SMN1; SMN2
SCHEMBL30152055 0.69 CDC14B (0.56) KDM4EMAOAMAPTALDH1A1SMN1; SMN2
SCHEMBL9107599 0.68 AHR (0.50) KDM4EMAOAMAPTALDH1A1SMN1; SMN2
SCHEMBL24073612 0.68 AHR (0.46) KDM4EMAOAMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260090261-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2026-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090261-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LBR, GLRA1, GLRA2 KDM4E 4579/4885MAOA 2092/4885MAPT 4577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.